Stay updated on Immunotherapy with TILs in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page has updated its date information, adding new dates in May 2025 while removing older dates from April 2025.
    Difference
    0.6%
    Check dated 2025-05-08T13:14:00.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.15.0 to v2.15.2 and has added new dates, specifically 2025-04-23 and 2025-04-24, while removing older dates from March 2025.
    Difference
    0.7%
    Check dated 2025-05-01T05:51:25.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about a study involving tumor-infiltrating lymphocytes (TIL) for various metastatic cancers, including the addition of specific cancer types and the drug Aldesleukin. The previous background information has been removed, which may affect the context of the study.
    Difference
    39%
    Check dated 2025-04-16T20:42:49.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T16:07:30.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.14.3, replacing the previous version v2.14.2. The estimated last update posted has been removed.
    Difference
    0.1%
    Check dated 2025-04-02T00:33:01.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has updated its date-related content, removing older dates and adding new ones. This indicates a refresh of time-sensitive information.
    Difference
    0.3%
    Check dated 2025-03-25T19:38:15.000Z thumbnail image

Stay in the know with updates to Immunotherapy with TILs in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with TILs in Metastatic Cancer Clinical Trial page.